Currently out of the existing stock ratings of Jack Wallace, 23 are a BUY (85.19%), 4 are a HOLD (14.81%).

Jack Wallace

Work Performance Price Targets & Ratings Chart

Analyst Jack Wallace, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 40.95% that have a potential upside of 37.12% achieved within 119 days.

Jack Wallace’s has documented 55 price targets and ratings displayed on 7 stocks. The coverage is on Consumer Defensive, Healthcare sectors.

Most recent stock forecast was given on VEEV, Veeva Systems at 01-Oct-2024.

Wall Street Analyst Jack Wallace

Analyst best performing recommendations are on NXGN (NEXTGEN HEALTHCARE).
The best stock recommendation documented was for NXGN (NEXTGEN HEALTHCARE) at 7/25/2023. The price target of $22 was fulfilled within 43 days with a profit of $5.84 (36.14%) receiving and performance score of 8.4.

Average potential price target upside

HIMS Hims Hers Health PHR Phreesia VEEV Veeva Systems AMWL American Well Corp HCAT Health Catalyst NXGN Nextgen Healthcare RCM R1 RCM

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Sell

$27

$22.4 (486.96%)

$27

29 days ago
(06-Mar-2025)

0/7 (0%)

$22.4 (486.96%)

Hold

$39

$34.4 (747.83%)

$24

29 days ago
(06-Mar-2025)

1/7 (14.29%)

$34.4 (747.83%)

6

Hold

$40

$35.4 (769.57%)

$40

29 days ago
(06-Mar-2025)

0/3 (0%)

$35.4 (769.57%)

Hold

$35

$30.4 (660.87%)

$35

29 days ago
(06-Mar-2025)

0/2 (0%)

$30.4 (660.87%)

Buy

$68

$63.4 (1378.26%)

$68

29 days ago
(06-Mar-2025)

0/3 (0%)

$63.4 (1378.26%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Jack Wallace?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?